Results 51 to 60 of about 832,435 (375)

Fetal Hemoglobin Induction by Epigenetic Drugs.

Seminars in hematology (Print), 2018
Fetal hemoglobin (HbF) inhibits the root cause of sickle pathophysiology, sickle hemoglobin polymerization. Individuals who naturally express high levels of HbF beyond infancy thus receive some protection from sickle complications.
D. Lavelle, J. D. Engel, Y. Saunthararajah   +2 more
semanticscholar   +1 more source

Correlation between maternal and umbilical cord blood in pregnant women of Pokhara Valley: a cross sectional study

BMC Pregnancy and Childbirth, 2018
Background Complete blood count is one of the routinely advised blood investigation during pregnancy. It is also utilized as a diagnostic tool for neonatal anemia, sepsis and determining hemostatic status of the newborn.
Sameer Timilsina, Sirisa Karki, Aajeevan Gautam, Pujan Bhusal, Gita Paudel, Deepak Sharma   +5 more
doaj   +1 more source

Evidence for multiple structural genes for the γ chain of human fetal hemoglobin [PDF]

, 1968
A sequence with a specific residue at each position was proposed for the γ chain of human fetal hemoglobin by Schroeder et al. (1) after a study in which hemoglobin from a number of individual infants was used.
Dozy, Andrée M., Huisman, T. H. J., Kleihauer, Enno F., Robberson, Barbara, Schroeder, W. A., Shelton, J. Roger, Shelton, Joan Balog   +6 more
core  

A validated cellular biobank for β-thalassemia [PDF]

, 2016
Background: Cellular biobanking is a key resource for collaborative networks planning to use same cells in studies aimed at solving a variety of biological and biomedical issues. This approach is of great importance in studies on β-thalassemia, since the
BIANCHI, Nicoletta, BORGATTI, Monica, BREDA, Laura, BREVEGLIERI, Giulia, Chiavilli, Francesco, COSENZA, Lucia Carmela, FINOTTI, Alessia, GAMBARI, Roberto, GAMBERINI, MARIA RITA, LAMPRONTI, Ilaria, Manunza, Laura, Martis, Franca Rosa, Moi, Paolo, Rivella, Stefano, Satta, Stefania, ZUCCATO, Cristina   +15 more
core   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia [PDF]

, 2017
Hydroxyurea treatment is recommended for children with sickle cell anemia (SCA) living in high-resource malaria-free regions, but its safety and efficacy in malaria-endemic sub-Saharan Africa, where the greatest sickle-cell burden exists, remain unknown.
Hodges, James S., Hume, Heather A., John, Chandy C., Kasirye, Phillip, Lane, Adam, Latham, Teresa S., Ndugwa, Christopher M., Opoka, Robert O., Ware, Russell E.   +8 more
core   +2 more sources

Fetal hemoglobin silencing in humans

Blood, 2006
AbstractInterruption of the normal fetal-to-adult transition of hemoglobin expression should largely ameliorate sickle cell and beta-thalassemia syndromes. Achievement of this clinical goal requires a robust understanding of gamma-globin gene and protein silencing during human development.
Naomi L. C. Luban, Naomi L. C. Luban, Nicole M. Gantt, Nicole M. Gantt, Joseph D. Schwartz, Joseph D. Schwartz, Natarajan V. Bhanu, Natarajan V. Bhanu, John W. Moroney, John W. Moroney, Jeffery L. Miller, Jeffery L. Miller, Christopher H. Reed, Christopher H. Reed, Patricia A. Oneal, Patricia A. Oneal, Alan N. Schechter, Alan N. Schechter, Y. Terry Lee, Y. Terry Lee   +19 more
openaire   +4 more sources

KLF1 drives the expression of fetal hemoglobin in British HPFH.

Blood, 2017
β-Hemoglobinopathies are among the most common single-locus inherited diseases. In this condition, high fetal hemoglobin (HbF) levels have been found to be beneficial, and boosting HbF expression is seen as an attractive therapy.
B. Wienert, Gabriella E Martyn, R. Kurita, Yukio Nakamura, K. Quinlan, M. Crossley   +5 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression

eLife, 2021
Mutations in the adult β-globin gene can lead to a variety of hemoglobinopathies, including sickle cell disease and β-thalassemia. An increase in fetal hemoglobin expression throughout adulthood, a condition named hereditary persistence of fetal ...
Pamela Himadewi, Xue Qing David Wang, Fan Feng, Haley Gore, Yushuai Liu, Lei Yu, Ryo Kurita, Yukio Nakamura, Gerd P Pfeifer, Jie Liu, Xiaotian Zhang   +10 more
doaj   +1 more source